AU7879294A - Method of treating septic shock using thymosin beta 4 - Google Patents

Method of treating septic shock using thymosin beta 4

Info

Publication number
AU7879294A
AU7879294A AU78792/94A AU7879294A AU7879294A AU 7879294 A AU7879294 A AU 7879294A AU 78792/94 A AU78792/94 A AU 78792/94A AU 7879294 A AU7879294 A AU 7879294A AU 7879294 A AU7879294 A AU 7879294A
Authority
AU
Australia
Prior art keywords
septic shock
thymosin beta
treating septic
treating
thymosin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU78792/94A
Inventor
Mirela O Fagarasan
Allan L. Goldstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
George Washington University
Original Assignee
George Washington University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/258,227 external-priority patent/US5578570A/en
Application filed by George Washington University filed Critical George Washington University
Publication of AU7879294A publication Critical patent/AU7879294A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2292Thymosin; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU78792/94A 1993-10-07 1994-09-27 Method of treating septic shock using thymosin beta 4 Abandoned AU7879294A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US258227 1988-10-14
US13285993A 1993-10-07 1993-10-07
US08/258,227 US5578570A (en) 1993-10-07 1994-06-10 Method of treating septic shock using thymosin β4
PCT/US1994/010879 WO1995009646A1 (en) 1993-10-07 1994-09-27 METHOD OF TREATING SEPTIC SHOCK USING THYMOSIN β¿4?
US132859 1998-08-11

Publications (1)

Publication Number Publication Date
AU7879294A true AU7879294A (en) 1995-05-01

Family

ID=26830805

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78792/94A Abandoned AU7879294A (en) 1993-10-07 1994-09-27 Method of treating septic shock using thymosin beta 4

Country Status (3)

Country Link
EP (1) EP0725652A1 (en)
AU (1) AU7879294A (en)
WO (1) WO1995009646A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2338928A1 (en) * 1998-07-30 2000-02-10 Hynda K. Kleinman Thymosin .beta.4 promotes wound repair
US9056087B2 (en) 2001-08-29 2015-06-16 Regenerx Biopharmaceuticals, Inc. Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4297276A (en) * 1979-03-23 1981-10-27 Hoffman-La Roche Inc. Thymosin beta 3 and beta 4

Also Published As

Publication number Publication date
WO1995009646A1 (en) 1995-04-13
EP0725652A1 (en) 1996-08-14

Similar Documents

Publication Publication Date Title
AU4032989A (en) Method and compositions for the treatment and prevention of septic shock
PL310548A1 (en) Method of burnishing structure components
HU9502565D0 (en) Method of treating solid waste
EP0452959A3 (en) Method of application
AU3406893A (en) Method and composition for the treatment of osteoporosis
AU3730093A (en) Methods of treating diabetes
PL313740A1 (en) Method of
ZA947751B (en) Method of treating septic shock using thymosin-alpha 1
AU1429792A (en) Method for the treatment of the sewages and respective plant
AU8299291A (en) Method of treating neurological dysfunction using neurotransmitter enhances
AU7879294A (en) Method of treating septic shock using thymosin beta 4
AU7366591A (en) Method and composition for water treatment
AU637873B2 (en) A method of treating erectile dysfunction
GB9202196D0 (en) Method of treatment
AU6276494A (en) Method for treating colic and constipation
AU7964194A (en) Method of treating septic shock using thymosin-alpha1
PH30221A (en) Method of treating ketosis
GB9316880D0 (en) Method of grinding
RU2003311C1 (en) Method of blepharorrhaphy
GB9201391D0 (en) Method of treatment
AU2321088A (en) Method for preventing or treating thrombocytopenia
AU6771594A (en) Method of decreasing the toxicity of therapeutic compositions using thymosin beta 4
HU9302724D0 (en) Developed method for intesification of degradation of pharmacentical sludges
GB9321971D0 (en) Method of treatment
GB9307004D0 (en) Method of treatment